abiraterone,pembrolizumab,enzalutamide,olaparib,prednisone
astrazeneca,merck,astellas,pfizer,janssen
[' enza ', 'olaparib', 'prostate', 'crpc', 'pembro']
keylink-010: pembro+olaparib vs abi or enza in mcrpc. io+parpi, although promising, doesn t seem to succeed in prostate cancer (at least in an unselected population) #esmo22 
Medical Oncologist - Urologic Oncology. Hospital Universitario La Paz - IdiPAZ, Madrid